Abstract
We examined possible effects and mechanisms involved in cardiac remodeling and vasculomyogenesis after injection of a clinically approved, porcine-derived small intestinal submucosa-extracellular matrix (SIS-ECM) injectable material, with and without circulating angiogenic cells (CACs), in a mouse model of post-infarction myocardial scar.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
